Xenetix

Xenetix (Iobitridol) is a non-ionic, low-osmolality contrast agent used for enhanced imaging in various diagnostic procedures. Suitable for intraarterial, intraarticular, and intrathecal use, it provides clear visualization of blood vessels and soft tissues. Xenetix is widely used in EU-based medical imaging.

Xenetix (Iobitridol) is primarily used as a contrast agent to improve the visibility of internal structures during imaging procedures. It helps in the visualization of blood vessels, joints, and other soft tissues when administered intraarterially, intraarticularly, or intrathecally. This enhanced imaging aids in accurate diagnosis and assessment of medical conditions.

Xenetix (Iobitridol) works by temporarily altering the density of tissues it comes into contact with, making them more visible under X-ray or CT scans. After administration, it is rapidly distributed and excreted unchanged by the kidneys, providing temporary contrast enhancement. Patients may experience a brief sensation of warmth or flushing during administration.

Xenetix should be used with caution in patients with known allergies to iodinated contrast agents or severe renal impairment. Adequate hydration before and after administration is recommended to support renal function. Healthcare professionals should monitor patients for signs of hypersensitivity reactions during and after use.

Concomitant use of certain medications, such as metformin or nephrotoxic drugs, may require temporary discontinuation or monitoring due to potential interactions. Alcohol and other substances that affect kidney function should be avoided around the time of administration. Always inform your healthcare provider about all medications and conditions before receiving Xenetix.